Bank of N.T Butterfield Bolsa (NYSE: NTB)

Últimas noticias sobre Bank of N.T Butterfield (NYSE:NTB) Bolsa

Bank of N.T Butterfield

Bank of N.T Butterfield & Son Ltd is a full-service bank and wealth manager. It operates the business through three geographic segments, Bermuda, Cayman Islands, the Channel Islands and the UK. The company offers banking services, comprised of retail and corporate banking, and wealth management, which consists of trust, private banking, and asset management. The company generates a majority of its revenue from Bermuda, and the Cayman Islands segments.

Bank of N.T. Butterfield & Son Limited (The) Voting Ordinary Shares

Bank of N.T Butterfield & Son Ltd

NOTABLE LABS INC ORD SHS

Notable Labs Ltd

NEW TRIPOLI BANCORP INC by New Tripoli Bancorp, Inc.

New Tripoli Bancorp Inc

NEW TYMBAL RES LTD by NEW TYMBAL RES LTD.

New Tymbal Resources Ltd

WIIM

TOPW

TOPW stock has given up its prior gain. Top Win International shares were trading higher after the company announced it launched a digital assets treasury strategy to participate in Asia's growing web3 ecosystem.

Wedbush analyst Laura Chico reiterates Travere Therapeutics (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/TVTX#NASDAQ">TVTX</a>) with a Outperform and maintains $30 price target.

News

Price Target

Reiteration

Analyst Ratings

TVTX

Wedbush Reiterates Outperform on Travere Therapeutics, Maintains $30 Price Target

Barclays analyst Brendan Lynch maintains Extra Space Storage (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/EXR#NYSE">EXR</a>) with a Overweight and lowers the price target from $181 to $178.

Barclays Maintains Overweight on Extra Space Storage, Lowers Price Target to $178

WENNU

Trading Halt: Halt status updated at 10:10:00 AM ET: Quotation Resumption: IPO Security - Released for Quotation

Barclays analyst Brendan Lynch maintains CubeSmart (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/CUBE#NYSE">CUBE</a>) with a Equal-Weight and lowers the price target from $49 to $48.

CUBE

Barclays Maintains Equal-Weight on CubeSmart, Lowers Price Target to $48

Wedbush analyst Yun Zhong reiterates Rocket Pharmaceuticals (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/RCKT#NASDAQ">RCKT</a>) with a Outperform and maintains $32 price target.

RCKT

Wedbush Reiterates Outperform on Rocket Pharmaceuticals, Maintains $32 Price Target

Barclays analyst Raimo Lenschow maintains MongoDB (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/MDB#NASDAQ">MDB</a>) with a Overweight and lowers the price target from $280 to $252.

Barclays Maintains Overweight on MongoDB, Lowers Price Target to $252

Bitcoin (CRYPTO: <a class="ticker" href="https://www.benzinga.com/quote/btc/usd">BTC</a>) rose 1.46% to reach $104,008.46, which took its weekly gains to 0.96%, <a href="https://www.benzinga.com/money/how-to-buy-bitcoin-btc-best-bonuses-august-2024">and monthly to 24.58%</a>. The rise follows JP Morgan Chase &amp; Co (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/JPM#NYSE">JPM</a>) analysts' prediction that Bitcoin could outperform gold this year, and growing support of corporate investment towards Bitcoin bull run.
According to Decrypt, the investment banking giant stated that maturing market infrastructure and increasing institutional adoption are the key factors driving Bitcoin&#8217;s strength over gold.
Don't Miss:
<ul class="wp-block-list">
<li><a href="https://www.benzinga.com/go/plus-500-crypto-in-content">Trade crypto futures on Plus500 with up to $200 in bonuses</a> — no wallets, just price speculation and free paper trading to practice different strategies.</li>
<li>New to trading crypto? <a href="http://coinbase-consumer.sjv.io/m5ALXy">Get up to $400 in rewards for successfully completing short educational courses and placing your first qualifying trade</a> on Coinbase.</li>
</ul>
JP Morgan explained that crypto-specific catalysts like corporate treasury flows, shifting regulation, and better derivatives infrastructure are helping Bitcoin. Recent decisions by major crypto exchanges, including Coinbase Global Inc's (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/COIN#NASDAQ">COIN</a>) takeover of Deribit, Kraken&#8217;s takeover of NinjaTrader, and Gemini&#8217;s new EU derivatives license, are signs of a regulated and investor-friendly industry.
While Bitcoin is performing well, gold has been on a downward trend, as investors resort to the former as a store of value in times of economic uncertainty and inflation.
JP Morgan&#8217;s Nikolaos Panigirtzoglou said that compared to gold, Bitcoin has more upside potential in the second half of 2025. Since more ETF inflows are going towards Bitcoin, risk appetite has returned.
Méliuz, a publicly traded fintech company in Brazil, recently became the country&#8217;s first &#8220;Bitcoin Treasury Company&#8221; by paying $28.4 million for 274.52 BTC. The firm now holds over 320 BTC and has seen its stock price increase 116% since the initial purchase of Bitcoin earlier this year.&nbsp;
New York&#8217;s DayDayCook bought 100 BTC as part of its strategy to accumulate 5,000 BTC in three years. The rising confidence among global businesses places Bitcoin as a legitimate store of value and corporate reserve.
A new SEC filing reported that the Wisconsin State Investment Board sold its full $300 million stake in BlackRock&#8217;s Bitcoin ETF in Q1, just before the U.S. initiated broad tariffs against China and other trading partners. The news, which was described as &#8220;Liberation Day,&#8221; triggered short-term volatility, sending Bitcoin temporarily below $75,000 last month. But Bitcoin has since regained its price as trade tensions relaxed and tariff policies eased in May.
Institutional opinion toward Bitcoin is still strong in spite of uncertainties and selloffs. JP Morgan&#8217;s predictions validate the argument that Bitcoin is increasingly a risk-on asset with high growth potential.
Bitcoin&#8217;s performance and institutional acceptance indicate that digital assets are no longer a second thought but a core component of modern investment portfolios. Whether as a hedge, growth asset, or balance sheet reserve, Bitcoin is moving steadily into the space once dominated by gold.
More Opportunities:
<ul class="wp-block-list">
<li>Grow your IRA or 401(k) with Crypto – <a href="https://info.irafinancial.com/lp/irafi-crypto/?utm_source=benzinga.com&amp;utm_medium=affiliate&amp;utm_campaign=y2">unlock the power of alternative investments including a Crypto IRA within your retirement account</a>.</li>
<li>Trade, earn, and grow your crypto portfolio with Crypto.com — <a href="https://www.benzinga.com/go/crypto-com-signup-bonus">plus receive up to $500 worth of rewards in the most popular tokens if you're a new customer</a>.</li>
</ul>
Image: Shutterstock

Coverage of Bitcoin, Etherum, Ripple and all the latest digital currencies.

Cryptocurrency

$BTC

COIN

Bitcoin Up 1.46% as JP Morgan Predicts It Will Outperform Gold, Public Companies Add Digital Assets

Barclays analyst Raimo Lenschow maintains Elastic (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/ESTC#NYSE">ESTC</a>) with a Overweight and lowers the price target from $138 to $124.

ESTC

Barclays Maintains Overweight on Elastic, Lowers Price Target to $124

<a href="https://storage.courtlistener.com/recap/gov.uscourts.ded.80479/gov.uscourts.ded.80479.141.0.pdf" title="https://storage.courtlistener.com/recap/gov.uscourts.ded.80479/gov.uscourts.ded.80479.141.0.pdf">https://storage.courtlistener.com/recap/gov.uscourts.ded.80479/gov.uscourts.ded.80479.141.0.pdf</a>

Legal

ACAD

Court Determines ACADIA Pharmaceuticals Demonstrated Evidence That Aurobindo Infringes Claims 4 And 5 Of U.S. Patent No. 11,452,721

Wedbush analyst David Nierengarten reiterates Nuvation Bio (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/NUVB#NYSE">NUVB</a>) with a Outperform and maintains $5 price target.

NUVB

Wedbush Reiterates Outperform on Nuvation Bio, Maintains $5 Price Target

Bank of America's chief investment strategist Michael Hartnett sees a powerful rotation in financial markets, with so-called "peace trades" now eclipsing "war trades" as the key driver of 2025 performance — a shift that could unleash the next bull <a href="https://www.benzinga.com/markets/emerging-markets">market in emerging markets.</a>
In his latest "The Flow Show" note shared Friday, Hartnett said a rare combination of falling oil prices, a weaker dollar, and a bond yield ceiling near 5% is reshaping the global investment landscape. The strategist cited a dramatic rally in emerging markets and sharp inflows to risk assets as signs of a growing consensus that diplomacy and disinflation are back in style.
<h3 class="wp-block-heading">&#8216;Peace Trades&#8217; Powering 2025 Market Leaders</h3>
"Big geopolitics = big price action," Hartnett said, highlighting that Tel Aviv and Tehran stock exchanges have hit all-time highs, Poland's market – tracked by the iShares Poland ETF (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/EPOL#NYSE">EPOL</a>) – is up 28%, and Russia's ruble is the best-performing currency this year, gaining 41%.
The top-performing asset year to date remains gold, up 22.1%, while oil is the worst, down 14% — a reversal Hartnett calls the "peace dividend." Stocks are up 5%, government bonds 4.3%, and the U.S. dollar is down 7.2%.
A potential &#8220;Riyadh Accord,&#8221; Hartnett said, could be driving this geopolitical detente. 
Lower oil prices may stem from behind-the-scenes deals between the U.S., OPEC and Russia, as Trump allegedly pursues lower inflation via energy diplomacy, rather than shale output.
<h3 class="wp-block-heading">30-Year Yield Is The Macro Pivot</h3>
Hartnett identified three macro pressure points: the 30-year Treasury yield at 5%, the U.S. dollar index at 100, and the SOX semiconductor index at 5000. 
If yields decisively breach the 5% threshold, stocks could falter. But for now, Hartnett says the level is holding, reinforcing the disinflation narrative.
A weak dollar, peak yields, and a Chinese economic recovery form the backbone of his next bull market thesis, with emerging markets ex-China – as tracked by the SPDR S&amp;P Emerging Markets Ex-China ETF (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/XCNY#NYSE">XCNY</a>) – already up 20% in the past month, breaking a 20-year trading range.
<h3 class="wp-block-heading">Flows Confirm The Rotation </h3>
Flows into risk assets have surged in recent weeks. Investors poured $25.2 billion into stocks and $13.1 billion into bonds last week, while pulling $17.5 billion from cash. 
Notably, U.S. equities saw their first inflow in five weeks at $19.8 billion, and financials drew in $1 billion, reversing a seven-week drought. Emerging market debt attracted $1.5 billion, its largest inflow since January 2023. Investment-grade and high-yield credit combined saw $8.6 billion, the biggest in 10 weeks. 
Gold, however, had a modest $0.4 billion outflow, despite being on track for a record $85 billion inflow in 2025.
<h3 class="wp-block-heading">A 1970s Or 1990s Outcome? </h3>
Hartnett said the key question for markets is whether the late 2020s will echo the &#8220;inflationary peace dividend&#8221; of the early 1970s or the &#8220;disinflationary peace dividend&#8221; of the early 1990s. 
The former involved volatile macro policy, oil shocks and protectionism; the latter delivered stable growth via globalization, deregulation and lower rates. 
He sees 2025 surprising with lower yields and disinflation, but warns that the secular outlook for government bonds remains bearish.
Read Next:
<ul class="wp-block-list">
<li><a href="https://www.benzinga.com/economics/macro-economic-events/25/05/45450466/what-recession-markets-have-erased-every-last-bit-of-economic-pessimism">What Recession? Markets Have Erased Every Last Bit Of Economic Pessimism </a></li>
</ul>
Photo: Shutterstock

Analyst Color

Equities

Large Cap

Macro Economic Events

Emerging Markets

Emerging Market ETFs

Global

Econ #s

Economics

Tech

ETFs

iShares MSCI Poland Investable Market Index Fund ETF

EPOL

XCNY

Emerging Markets Break Out As 'Peace Trades' Gain Momentum, Hartnett Says

Top Wall Street analysts changed their outlook on these top names. For a complete view of all analyst rating changes, including upgrades and downgrades, please see our <a href="https://www.benzinga.com/analyst-stock-ratings">analyst ratings page</a>.
<ul class="wp-block-list">
<li>Needham raised Endava plc (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/DAVA#NYSE">DAVA</a>) price target from $13 to $17. Needham analyst John Todaro maintained a Buy rating. Endava shares closed at $13.73 on Thursday. See how other <a href="https://www.benzinga.com/quote/DAVA/analyst-ratings">analysts view this stock</a>.</li>
<li>Telsey Advisory Group cut the price target for Target Corporation (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/TGT#NYSE">TGT</a>) from $145 to $130. Telsey Advisory Group analyst Joseph Feldman maintained an Outperform rating. Target shares closed at $97.07 on Thursday. See how other analysts <a href="https://www.benzinga.com/quote/TGT/analyst-ratings">view this stock</a>.</li>
<li>HC Wainwright &amp; Co. cut BiomX Inc. (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/PHGE#NYSE">PHGE</a>) price target from $21 to $15. HC Wainwright &amp; Co. analyst Joseph Pantginis maintained a Buy rating. BiomX shares closed at $0.5637 on Thursday. See how other <a href="https://www.benzinga.com/quote/PHGE/analyst-ratings">analysts view this stock</a>.</li>
<li>Chardan Capital raised the price target for Rocket Pharmaceuticals, Inc. (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/RCKT#NASDAQ">RCKT</a>) from $45 to $46. Chardan Capital analyst Geulah Livshits maintained a Buy rating. Rocket Pharmaceuticals shares closed at $6.72 on Thursday. <a href="https://www.benzinga.com/quote/RCKT/analyst-ratings">See how other analysts view this stock.</a></li>
<li>JP Morgan raised the price target for Pentair plc (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/PNR#NYSE">PNR</a>) from $90 to $113. JP Morgan analyst Stephen Tusa upgraded the stock from Neutral to Overweight. Pentair shares closed at $97.81 on Thursday. See how other <a href="https://www.benzinga.com/quote/PNR/analyst-ratings">analysts view this stock</a>.</li>
<li>Barclays raised Foot Locker, Inc. (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/FL#NYSE">FL</a>) price target from $14 to $24. Barclays analyst Adrienne Yih downgraded the stock from Overweight to Equal-Weight. Foot Locker shares settled at $23.90 on Thursday. <a href="https://www.benzinga.com/quote/FL/analyst-ratings">See how other analysts view this stock</a>.</li>
<li>Telsey Advisory Group slashed DICK&#8217;S Sporting Goods, Inc. (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/DKS#NYSE">DKS</a>) price target from $250 to $220. Telsey Advisory Group analyst Joseph Feldman maintained an Outperform rating. Dick&#8217;s Sporting shares closed at $179.05 on Thursday. <a href="https://www.benzinga.com/quote/DKS/analyst-ratings">See how other analysts view this stock.</a></li>
<li>Needham increased CoreWeave, Inc. (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/CRWV#NASDAQ">CRWV</a>) price target from $55 to $78. Needham analyst Mike Cikos maintained a Buy rating. CoreWeave shares closed at $65.77 on Thursday.  <a href="https://www.benzinga.com/quote/CRWV/analyst-ratings">See how other analysts view this stock</a>.</li>
<li>HC Wainwright &amp; Co. cut the price target for Bicara Therapeutics Inc. (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/BCAX#NASDAQ">BCAX</a>) from $44 to $41. HC Wainwright &amp; Co. analyst Robert Burns maintained a Buy rating. Bicara Therapeutics shares settled at $14.47 on Thursday. <a href="https://www.benzinga.com/quote/BCAX/analyst-ratings">See how other analysts view this stock</a>.</li>
<li>UBS raised Caterpillar Inc. (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/CAT#NYSE">CAT</a>) price target from $272 to $357. UBS analyst Steven Fisher upgraded the stock from Sell to Neutral. Caterpillar shares closed at $349.81 on Thursday. <a href="https://www.benzinga.com/quote/CAT/analyst-ratings">See how other analysts view this stock</a>.</li>
</ul>
Considering buying PNR stock? Here&#8217;s what analysts think: 
<figure class="wp-block-image size-large is-resized"><img loading="lazy" decoding="async" width="1024" height="607" src="https://editorial-assets.benzinga.com/wp-content/uploads/2025/05/16100229/image-199-1024x607.png" alt="" class="wp-image-917984" style="width:654px;height:auto" srcset="https://editorial-assets.benzinga.com/wp-content/uploads/2025/05/16100229/image-199-1024x607.png 1024w,https://editorial-assets.benzinga.com/wp-content/uploads/2025/05/16100229/image-199-300x178.png 300w,https://editorial-assets.benzinga.com/wp-content/uploads/2025/05/16100229/image-199-768x456.png 768w,https://editorial-assets.benzinga.com/wp-content/uploads/2025/05/16100229/image-199.png 1116w" sizes="(max-width: 1024px) 100vw, 1024px" /></figure>
Read This Next: 
<ul class="wp-block-list">
<li><a href="https://www.benzinga.com/25/05/45462276/applied-materials-flowers-foods-and-3-stocks-to-watch-heading-into-friday">Applied Materials, Flowers Foods And 3 Stocks To Watch Heading Into Friday</a></li>
</ul>

Markets

Trading Ideas

BCAX

CRWV

DAVA

PHGE

Pentair To Rally More Than 15%? Here Are 10 Top Analyst Forecasts For Friday

<a href="https://www.cnbc.com/2025/05/16/nvidia-chips-china-shanghai.html">https://www.cnbc.com/2025/05/16/nvidia-chips-china-shanghai.html</a>

General

NVDA

'Nvidia says it is not sending GPU designs to China after reports of new Shanghai operation'- CNBC

Barclays analyst Ryan Macwilliams maintains Braze (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/BRZE#NASDAQ">BRZE</a>) with a Overweight and lowers the price target from $70 to $47.

BRZE

Barclays Maintains Overweight on Braze, Lowers Price Target to $47

<a href="https://www.benzinga.com/money/how-to-buy-solana">Solana (CRYPTO: <a class="ticker" href="https://www.benzinga.com/quote/sol/usd">SOL</a>) is trading at $172.98</a>, with a dip of 0.14% in the last 24 hours. The dip came after the users witnessed an NFT hack, in spite of the growing institutional use case of SOL.
The hack was an alarming incident involving Frank (Rohun Vora), the guy behind the DeGods NFT project. Vora's Solana wallet got hacked, and led to the sale of 16 DeGods NFTs, including a rare mythical helmet.&nbsp; The NFTs were sold for over 108 SOL, which is around $19,000. According to Decrypt, Vora did not sell the NFT's on his own as it was due to a security breach.&nbsp;
Don't Miss:
<ul class="wp-block-list">
<li><a href="https://www.benzinga.com/go/plus-500-crypto-in-content">Trade crypto futures on Plus500 with up to $200 in bonuses</a> — no wallets, just price speculation and free paper trading to practice different strategies.</li>
<li>New to trading crypto? <a href="http://coinbase-consumer.sjv.io/m5ALXy">Get up to $400 in rewards for successfully completing short educational courses and placing your first qualifying trade</a> on Coinbase.</li>
</ul>
According to The CoinRepublic, Solana's layer 2 ambitions have gotten a major boost with Solaxy, Solana's first layer 2 solution, raising an impressive $36 million in funding. The ICO has gained over $600,000 in the past 24 hours, boosting investor confidence in Solana's layer 2 solutions and scalability.
The Sygnum Bank, a digital asset bank out of Switzerland, has signed an agreement to begin accepting staked Solana as collateral for loans. Institutional clients can get liquidity while still earning staking rewards. Sygnum&#8217;s loan volumes have doubled in the past year.
The Market Value to Realized Value (MVRV) ratio sits at 1.3 because SOL isn't in the overbought zone. It gives users some breathing space for the Solana price to potentially rise further. According to BeInCrypto, there could be an opportunity for investors to scoop up more SOL.
According to BeInCrypto, Solana is getting close to what's known as a &#8220;Golden Cross&#8221; as the 50-day moving average climbed above the 200-day moving average. If this happens, we could be looking at a potential rally of around 50%.
Analysts note that the token has formed a bullish "cup and handle" pattern, a continuation structure that usually precedes an upward breakout. According to crypto analyst Ali, a successful move above the $200 level could confirm the bullish formation.&nbsp;
Signalling an upward momentum and growing investor confidence, Ali believes it could lead to higher buying pressure and a spike in SOL prices.
The $200 mark seems to be a tipping point, with a breakout propelling Solana to $220 and all-time highs.
Currently, Solana is trading in the $170-$185 range, with the price retracing from the recent highs. The price broke above the 200-day EMA at $162.21 and the 200-day SMA at $181.16, indicating upward momentum before facing rejection at the $185 resistance.
On the downside, the support at $162 remains crucial. A break below this region could trigger bearish momentum, pushing Solana prices down to $150.
Amidst the ups and downs, the core fundamentals for Solana are still looking solid. Investors should keep a close watch on all these developments as Solana price tries to find its footing.&nbsp;
More Opportunities:
<ul class="wp-block-list">
<li>Grow your IRA or 401(k) with Crypto – <a href="https://info.irafinancial.com/lp/irafi-crypto/?utm_source=benzinga.com&amp;utm_medium=affiliate&amp;utm_campaign=y2">unlock the power of alternative investments including a Crypto IRA within your retirement account</a>.</li>
<li>Trade, earn, and grow your crypto portfolio with Crypto.com — <a href="https://www.benzinga.com/go/crypto-com-signup-bonus">plus receive up to $500 worth of rewards in the most popular tokens if you're a new customer</a>.</li>
</ul>
Image: Shutterstock

$SOL

Solana Price Dips Amid NFT Hack; But Golden Cross Is Near

Barclays analyst Tom O'Malley maintains Advanced Micro Devices (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/AMD#NASDAQ">AMD</a>) with a Overweight and raises the price target from $110 to $130.

Barclays Maintains Overweight on Advanced Micro Devices, Raises Price Target to $130

Wedbush analyst Laura Chico reiterates Gossamer Bio (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/GOSS#NASDAQ">GOSS</a>) with a Outperform and maintains $4 price target.

GOSS

Wedbush Reiterates Outperform on Gossamer Bio, Maintains $4 Price Target

Compugen (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/CGEN#NASDAQ">CGEN</a>) is set to give its latest quarterly earnings report on Monday, 2025-05-19. Here's what investors need to know before the announcement.
Analysts estimate that Compugen will report an earnings per share (EPS) of $-0.05. 
Investors in Compugen are eagerly awaiting the company's announcement, hoping for news of surpassing estimates and positive guidance for the next quarter.
It's worth noting for new investors that stock prices can be heavily influenced by future projections rather than just past performance.
<h3>Earnings History Snapshot</h3>
Last quarter the company missed EPS by $0.14, which was followed by a 7.74% increase in the share price the next day.
Here's a look at Compugen's past performance and the resulting price change:

<table>
<thead>
<tr>
<th>Quarter</th>
<th>Q4 2024</th>
<th>Q3 2024</th>
<th>Q2 2024</th>
<th>Q1 2024</th>
</tr>
</thead>
<tbody>
<tr>
<td>EPS Estimate</td>
<td>0.07</td>
<td>0.10</td>
<td>-0.07</td>
<td>-0.02</td>
</tr>
<tr>
<td>EPS Actual</td>
<td>-0.07</td>
<td>0.01</td>
<td>-0.02</td>
<td>-0.08</td>
</tr>
<tr>
<td>Price Change %</td>
<td>8.0%</td>
<td>-1.0%</td>
<td>-5.0%</td>
<td>7.000000000000001%</td>
</tr>
</tbody>
</table>

<img src="https://www.benzinga.com/files/images/story/2025/1747404126_0.png" alt="eps graph" />
<h3>Performance of Compugen Shares</h3>
Shares of Compugen were trading at $1.37 as of May 15. Over the last 52-week period, shares are down 20.69%. Given that these returns are generally negative, long-term shareholders are likely upset going into this earnings release. 
<a href="https://www.benzinga.com/quote/CGEN/earnings">To track all earnings releases for Compugen visit their earnings calendar on our site.</a>
This article was generated by Benzinga's automated content engine and reviewed by an editor.

Earnings

CGEN

Uncovering Potential: Compugen's Earnings Preview

Global Ship Lease (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/GSL#NYSE">GSL</a>) is set to give its latest quarterly earnings report on Monday, 2025-05-19. Here's what investors need to know before the announcement.
Analysts estimate that Global Ship Lease will report an earnings per share (EPS) of $2.31. 
Global Ship Lease bulls will hope to hear the company announce they've not only beaten that estimate, but also to provide positive guidance, or forecasted growth, for the next quarter.
New investors should note that it is sometimes not an earnings beat or miss that most affects the price of a stock, but the guidance (or forecast).
<h3>Performance in Previous Earnings</h3>
In the previous earnings release, the company beat EPS by $0.24, leading to a 0.95% increase in the share price the following trading session.
Here's a look at Global Ship Lease's past performance and the resulting price change:

<table>
<thead>
<tr>
<th>Quarter</th>
<th>Q4 2024</th>
<th>Q3 2024</th>
<th>Q2 2024</th>
<th>Q1 2024</th>
</tr>
</thead>
<tbody>
<tr>
<td>EPS Estimate</td>
<td>2.31</td>
<td>2.41</td>
<td>2.29</td>
<td>2.27</td>
</tr>
<tr>
<td>EPS Actual</td>
<td>2.55</td>
<td>2.45</td>
<td>2.46</td>
<td>2.53</td>
</tr>
<tr>
<td>Price Change %</td>
<td>1.0%</td>
<td>-0.0%</td>
<td>6.0%</td>
<td>2.0%</td>
</tr>
</tbody>
</table>

<img src="https://www.benzinga.com/files/images/story/2025/1747404117_0.png" alt="eps graph" />
<h3>Market Performance of Global Ship Lease's Stock</h3>
Shares of Global Ship Lease were trading at $24.75 as of May 15. Over the last 52-week period, shares are down 7.89%. Given that these returns are generally negative, long-term shareholders are likely bearish going into this earnings release. 
<h3>Insights Shared by Analysts on Global Ship Lease</h3>
For investors, grasping market sentiments and expectations in the industry is vital. This analysis explores the latest insights regarding Global Ship Lease.
With 1 analyst ratings, Global Ship Lease has a consensus rating of Buy. The average one-year price target is $29.0, indicating a potential 17.17% upside.
<h3>Analyzing Analyst Ratings Among Peers</h3>
This comparison focuses on the analyst ratings and average 1-year price targets of Genco Shipping &amp; Trading, Safe Bulkers and Golden Ocean Group, three major players in the industry, shedding light on their relative performance expectations and market positioning.
<ul>
<li>Analysts currently favor an Buy trajectory for Genco Shipping &amp; Trading, with an average 1-year price target of $18.0, suggesting a potential 27.27% downside.</li>
<li>Analysts currently favor an Buy trajectory for Safe Bulkers, with an average 1-year price target of $6.0, suggesting a potential 75.76% downside.</li>
<li>Analysts currently favor an Neutral trajectory for Golden Ocean Group, with an average 1-year price target of $9.0, suggesting a potential 63.64% downside.</li>
</ul>
<h3>Analysis Summary for Peers</h3>
The peer analysis summary provides a snapshot of key metrics for Genco Shipping &amp; Trading, Safe Bulkers and Golden Ocean Group, illuminating their respective standings within the industry. These metrics offer valuable insights into their market positions and comparative performance.

<table>
<thead>
<tr>
<th>Company</th>
<th>Consensus</th>
<th>Revenue Growth</th>
<th>Gross Profit</th>
<th>Return on Equity</th>
</tr>
</thead>
<tbody>
<tr>
<td>Global Ship Lease</td>
<td>Buy</td>
<td>2.28%</td>
<td>$99.10M</td>
<td>6.33%</td>
</tr>
<tr>
<td>Genco Shipping &amp; Trading</td>
<td>Buy</td>
<td>-39.31%</td>
<td>$-951K</td>
<td>-1.30%</td>
</tr>
<tr>
<td>Safe Bulkers</td>
<td>Buy</td>
<td>-13.12%</td>
<td>$32.87M</td>
<td>2.10%</td>
</tr>
<tr>
<td>Golden Ocean Group</td>
<td>Neutral</td>
<td>-17.01%</td>
<td>$39.56M</td>
<td>2.04%</td>
</tr>
</tbody>
</table>

Key Takeaway:
Global Ship Lease ranks at the top for Revenue Growth with 2.28%. It is at the bottom for Gross Profit with $99.10M. For Return on Equity, it is at the top with 6.33%.
<h3>Unveiling the Story Behind Global Ship Lease</h3>
Global Ship Lease Inc operates in the container shipping industry. The company owns and charters out containerships under long-term, fixed-rate charters to container liner companies. The majority of the company's revenues are derived from charters to MAERSK. Its fleet consisted of more than 60 containerships.
<h3>Global Ship Lease: A Financial Overview</h3>
Market Capitalization: Indicating a reduced size compared to industry averages, the company's market capitalization poses unique challenges.
Revenue Growth: Over the 3 months period, Global Ship Lease showcased positive performance, achieving a revenue growth rate of 2.28% as of 31 December, 2024. This reflects a substantial increase in the company's top-line earnings. As compared to competitors, the company encountered difficulties, with a growth rate lower than the average among peers in the Industrials sector.
Net Margin: The company's net margin is a standout performer, exceeding industry averages. With an impressive net margin of 49.71%, the company showcases strong profitability and effective cost control.
Return on Equity (ROE): Global Ship Lease's financial strength is reflected in its exceptional ROE, which exceeds industry averages. With a remarkable ROE of 6.33%, the company showcases efficient use of equity capital and strong financial health.
Return on Assets (ROA): Global Ship Lease's ROA stands out, surpassing industry averages. With an impressive ROA of 3.91%, the company demonstrates effective utilization of assets and strong financial performance.
Debt Management: The company maintains a balanced debt approach with a debt-to-equity ratio below industry norms, standing at 0.47.
<a href="https://www.benzinga.com/quote/GSL/earnings">To track all earnings releases for Global Ship Lease visit their earnings calendar on our site.</a>
This article was generated by Benzinga's automated content engine and reviewed by an editor.

Earnings Outlook For Global Ship Lease

Press Releases

Butterfield Reports Second Quarter 2024 Results

Butterfield Announces Senior Management Appointments

Butterfield to Announce Third Quarter 2024 Financial Results on October 22, 2024 and Host Earnings Conference Call on October 23, 2024

Butterfield Reports Third Quarter 2024 Results

Butterfield Announces New Share Repurchase Program

Butterfield to Announce Fourth Quarter and Full Year 2024 Financial Results on February 10, 2025 and Host Earnings Conference Call on February 11, 2025

Comments

Bank of N.T Butterfield

Noticias

Últimas noticias sobre Bank of N.T Butterfield (NYSE:NTB) Bolsa

Noticias

SOCIO/CONTRIBUIDOR

BENZINGA GLOBAL